nad has been researched along with Cystic Fibrosis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Atlante, A; Favia, M | 1 |
| Boucher, RC; Gabriel, SE; Olsen, JC; Price, EM; Sarkadi, B; Stutts, MJ | 1 |
| Britigan, BE; Cox, CD; Railsback, MA | 1 |
3 other study(ies) available for nad and Cystic Fibrosis
| Article | Year |
|---|---|
Cellular Redox State Acts as Switch to Determine the Direction of NNT-Catalyzed Reaction in Cystic Fibrosis Cells.
Topics: Catalysis; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Energy Metabolism; Humans; Membrane Potential, Mitochondrial; Metabolic Networks and Pathways; Mitochondria; NAD; NADP; NADP Transhydrogenases; Oxidation-Reduction; Reactive Oxygen Species | 2021 |
Pyridine nucleotide redox potential modulates cystic fibrosis transmembrane conductance regulator Cl- conductance.
Topics: 3T3 Cells; Adenosine Triphosphate; Animals; Chloride Channels; Chlorides; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Ion Channel Gating; Membrane Proteins; Mice; Moths; NAD; NADP; Oxidation-Reduction; Recombinant Proteins | 1994 |
The Pseudomonas aeruginosa secretory product pyocyanin inactivates alpha1 protease inhibitor: implications for the pathogenesis of cystic fibrosis lung disease.
Topics: alpha 1-Antitrypsin; Cystic Fibrosis; Humans; Lung Diseases; NAD; Oxidation-Reduction; Pseudomonas aeruginosa; Pyocyanine; Reactive Oxygen Species; Superoxides; Tumor Cells, Cultured | 1999 |